COMPARATIVE SAFETY OF SGLT2 AND DPP-4 INHIBITORS ON RISK OF ADVERSE EVENTS IN MIDDLE-AGED ADULTS WITH TYPE 2 DIABETES MELLITUS
May 1, 2016, 00:00
10.1016/j.jval.2016.03.1308
https://www.valueinhealthjournal.com/article/S1098-3015(16)01376-0/fulltext
Title :
COMPARATIVE SAFETY OF SGLT2 AND DPP-4 INHIBITORS ON RISK OF ADVERSE EVENTS IN MIDDLE-AGED ADULTS WITH TYPE 2 DIABETES MELLITUS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)01376-0&doi=10.1016/j.jval.2016.03.1308
First page :
A196
Section Title :
Diabetes/Endocrine Disorders - Clinical Outcomes Studies
Open access? :
No
Section Order :
590